Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Shoulson

Showing results (81-90 of 108) with videos related to

Pageof 11
Sort By:
Science (New York, N.Y.)|August 19, 1988
NMDA receptor losses in putamen from patients with Huntington's diseaseA B Young, J T Greenamyre, Z Hollingsworth, et al.
Clinical Pharmacology and Therapeutics|October 8, 1999
Acute tolerance to methylphenidate in the treatment of attention deficit hyperactivity disorder in childrenJ Swanson, S Gupta, D Guinta, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 1, 1996
Assessment of coenzyme Q10 tolerability in Huntington's diseaseA Feigin, K Kieburtz, P Como, et al.
Annals of Neurology|January 1, 1977
Cerebrospinal fluid norepinephrine reductions in man after degeneration and electrical stimulation of the caudate nucleusJ H Wood, M G Ziegler, C R Lake, et al.
Transactions of the American Neurological Association|January 1, 1976
Norepinephrine reductions in cerebrospinal fluid in man after electrical stimulation and degeneration of the caudate nucleusJ H Wood, M G Ziegler, C R Lake, et al.
Acta Neuropathologica|October 1, 1996
Coexistence of Huntington's disease and familial amyotrophic lateral sclerosis: case presentationA Rubio, K Steinberg, D A Figlewicz, et al.
Annals of Neurology|June 1, 1988
Duodenal and gastric delivery of levodopa in parkinsonismR Kurlan, J G Nutt, W R Woodward, et al.
Annals of Neurology|March 1, 1989
A controlled clinical trial of baclofen as protective therapy in early Huntington's diseaseI Shoulson, C Odoroff, D Oakes, et al.
Clinical Pharmacology and Therapeutics|December 1, 1978
Parotid and whole saliva in the prediction of serum total and free phenytoin concentrationsS N Anavekar, R H Saunders, W M Wardell, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 1, 1995
Functional decline in Huntington's diseaseA Feigin, K Kieburtz, K Bordwell, et al.
Pageof 11

Showing results (81-90 of 108) with videos related to

Sort By:
Pageof 11
Science (New York, N.Y.)|August 19, 1988
NMDA receptor losses in putamen from patients with Huntington's diseaseA B Young, J T Greenamyre, Z Hollingsworth, et al.
Clinical Pharmacology and Therapeutics|October 8, 1999
Acute tolerance to methylphenidate in the treatment of attention deficit hyperactivity disorder in childrenJ Swanson, S Gupta, D Guinta, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 1, 1996
Assessment of coenzyme Q10 tolerability in Huntington's diseaseA Feigin, K Kieburtz, P Como, et al.
Annals of Neurology|January 1, 1977
Cerebrospinal fluid norepinephrine reductions in man after degeneration and electrical stimulation of the caudate nucleusJ H Wood, M G Ziegler, C R Lake, et al.
Transactions of the American Neurological Association|January 1, 1976
Norepinephrine reductions in cerebrospinal fluid in man after electrical stimulation and degeneration of the caudate nucleusJ H Wood, M G Ziegler, C R Lake, et al.
Acta Neuropathologica|October 1, 1996
Coexistence of Huntington's disease and familial amyotrophic lateral sclerosis: case presentationA Rubio, K Steinberg, D A Figlewicz, et al.
Annals of Neurology|June 1, 1988
Duodenal and gastric delivery of levodopa in parkinsonismR Kurlan, J G Nutt, W R Woodward, et al.
Annals of Neurology|March 1, 1989
A controlled clinical trial of baclofen as protective therapy in early Huntington's diseaseI Shoulson, C Odoroff, D Oakes, et al.
Clinical Pharmacology and Therapeutics|December 1, 1978
Parotid and whole saliva in the prediction of serum total and free phenytoin concentrationsS N Anavekar, R H Saunders, W M Wardell, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 1, 1995
Functional decline in Huntington's diseaseA Feigin, K Kieburtz, K Bordwell, et al.
Pageof 11